Dec 09, 2019

Scientists Reverse The Effects Of Dementia For The First Time Ever

A groundbreaking new study that has seen scientists successfully reverse the effects of dementia is changing the way the scientific world once viewed the disease.

The majority of dementia treatments have focused on trying to remove amyloid plaque from the brain, however, the latest study published in Science Translational Medicine suggest that targeting brain inflammation is the silver-bullet for curing dementia.

New evidence suggests that the cause of Alzheimer’s – which is the most common form of dementia – is actually the result of leakage from the brains ‘filtration system’ known as the blood-brain barrier.

The blood-brain barrier is a border within the brain that separates circulating blood from a variety of different fluids in the central nervous system.

Previous MRI scans have found that the blood-brain barrier breaks down in nearly 60% of people by the age of 70, and it is believed that this allows harmful chemicals to seep through which is triggering inflammation and fog throughout the brain.

Experiments that were conducted on mice showed that this fog alters brain rhythms which leads to momentary lapses in the area of the brain that controls memory.

The mice were given a drug called IPW that blocks a brain receptor known as TGF-β which triggers an inflammation-causing blood protein, and the results are nothing short of astounding.

The drug reduced inflammation in the brains of senile mice and scans revealed that their brains actually looked and functioned similarly to mice of a much younger age.

The mice were also able to navigate a maze and had regained their ability to learn spatial tasks similar to a young mouse.

Experts are optimistic that this approach will have the same effect on humans and possibly lead to a cure for dementia, and there is also hope the same strategy could help people mentally recover from strokes, concussions and brain injuries.

Leaking blood-brain barriers and abnormal brain rhythms are detectable by a number of scans, and this new discovery could be used to accurately diagnose dementia and signal the time to intervene and use a drug to stop the disease.

Scientists involved with this study have now started a company to develop a drug that will be used to heal leakage in the blood-brain barrier of humans and potentially improve the lives of millions across the globe living with dementia.

Leave a Reply

Your email address will not be published. Required fields are marked *

  1. Hi Jakob,
    Very interesting article, I recently heard of a story that may interest you. A friends brother was suffering from a lung infection and being treated with anti-biotics, he is 51 and was responding well to the drug. Then about 8 months ago he woke up on morning with no memory of who he was his family or surroundings. Doctors conducted tests and MRI’s and diagnosed early onset dementia. The months that followed family & friends attempted to work with him to restore his memory, with Que cards and photographic images, eventually he restored his memory and to this day he now recalls people, faces and even recipes ( he use to cook). Somehow his diagnosis has baffled everyone, his family are as you expect delighted with his memory restoration, but nobody is able to explain how it came about.
    My thoughts are that possibly the anti-biotics worked against the plaque build up in his brain.
    If you would like to discuss more you can contact me on pavman2@hotmail.com or 0428952806

    Kind regards,
    Michael Preston
    December 2019

Advertisement
Advertisement
Advertisement

Caregiver Stress Check: Know Your Limits

With more 330,000 people in Australia with dementia, there are about 1.2 million people in Australia involved in the care of someone with dementia. As you can see dementia doesn’t only affect those who are diagnosed with the condition, it affects people on the peripheral – individuals and families caring for them. The University College... Read More

“A slow and painful journey”: Why did it take over 20 years to approve the new Alzheimer’s drug?

There’s considerable support from patient groups and many doctors and scientists for the early approval of this drug, but there are some who don’t agree with this decision. Read More

Transforming the capability of the dementia workforce: “68% of residents are known to have moderate to severe cognitive impairment”

The federal government’s response to the Royal Commission’s findings is a rare opportunity to make a once-in-a-lifetime difference to the experience of people impacted by dementia, says Dementia Australia CEO Maree McCabe. Read More
Advertisement